Carle Cancer Center Community Clinical Oncology Program

描述(由申请人提供)： 作为对RFA CA-07-048的响应，国家癌症研究所、伊利诺伊州厄巴纳的卡尔癌症中心的社区临床肿瘤学计划正在申请继续资助伊利诺伊州中东部的CCOP。作为伊利诺伊州最大的私人医疗团体，Carle Clinic Association拥有334名医生，拥有完善的癌症中心项目，自1976年以来一直参与全国临床试验研究。卡勒癌症中心自1983年项目开始以来，一直作为CCOP得到资助。与Carle一起参与CCOP申请的机构包括伊利诺伊州奥罗拉的Rush-Copley医疗中心、伊利诺伊州Joliet的Joliet肿瘤学-血液学协会和印第安纳州密歇根市的St.Anthony纪念健康中心。合并后的Carle癌症中心CCOP在伊利诺伊州中东部和印第安纳州西部的32个县、芝加哥南部和西南部的10个县以及印第安纳州西北部的4个县的集水区内为癌症患者提供服务。CCOP的主要运营中心位于卡勒癌症中心，所有随机、管理和质量保证计划都在伊利诺伊州的厄巴纳管理。CCOP的主要研究基地是北中癌症治疗小组。还与东部合作肿瘤学小组和国家外科辅助乳肠项目有很强的联系。此外，2003年与癌症试验支持股建立了新的联系，并于2004年与妇科肿瘤组建立了新的联系。Carle癌症中心及其附属机构拥有专门的临床研究专业人员、护士和行政人员，协助多学科医生团队进行临床试验，平均每年产生174个治疗学分和260个癌症控制/预防学分。Carle癌症中心CCOP的目标是为社区内的个人提供和促进广泛的癌症治疗和预防机会。CCOP致力于通过正在进行的科学研究降低癌症发病率和死亡率，并以造福所有患者的方式应用研究知识。Carle癌症中心CCOP认为，保持对癌症治疗和预防临床试验的参与至关重要，以便为目前的患者提供最高标准的癌症护理，并为子孙后代带来最好的希望。

Description (provided by applicant): In response to RFA CA-07-048, Community Clinical Oncology Program, National Cancer Institute, the Carle Cancer Center, Urbana, Illinois is applying for continued funding as a CCOP in East Central Illinois. As the largest private medical group practice in Illinois, with 334 physicians, the Carle Clinic Association has a fully developed cancer center program which has been involved in national clinical trial research since 1976. The Carle Cancer Center has been continuously funded as a CCOP since the program's inception in 1983. Joining Carle in this CCOP application as component institutions are Rush- Copley Medical Center in Aurora, Illinois, Joliet Oncology-Hematology Associates in Joliet, Illinois, and St. Anthony Memorial Health Center, in Michigan City, Indiana. The combined Carle Cancer Center CCOP provides services to cancer patients within a catchment area of 32 counties in east central Illinois and western Indiana, 10 counties south and southwest of Chicago, and 4 counties in northwestern Indiana. The primary center of operations for the CCOP is located at the Carle Cancer Center with all randomizations, administration, and quality assurance programs managed in Urbana, Illinois. The CCOP's primary research base is the North Central Cancer Treatment Group. There are also strong affiliations with the Eastern Cooperative Oncology Group and the National Surgical Adjuvant Breast and Bowel Project. Additionally, new affiliations were established with the Cancer Trials Support Unit in 2003 and with the Gynecologic Oncology Group in 2004. The Carle Cancer Center and its affiliates have dedicated clinical research professionals, nurses, and administrative staff to assist a multidisciplinary physician team in clinical trials that result in an average of 174 treatment credits and 260 cancer control/prevention credits annually. The goal of the Carle Cancer Center CCOP is to offer and facilitate a wide range of cancer treatment and prevention opportunities to individuals within their communities. The CCOP is dedicated to reducing cancer incidence and mortality through ongoing scientific research and to applying knowledge from research in ways that benefit all patient populations. The Carle Cancer Center CCOP believes that it is vital to maintain participation in cancer treatment and prevention clinical trials in order to provide the highest standard of cancer care to present patients and the best possible hope to future generations.